Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
114.61M | 101.08M | 94.47M | 83.83M | 50.80M | 8.35M | Gross Profit |
27.20M | 21.28M | 17.92M | 19.29M | 11.14M | -3.71M | EBIT |
-10.50M | -19.00M | -46.79M | -42.01M | -54.03M | -61.05M | EBITDA |
-31.61M | -10.82M | -93.40M | -13.64M | -57.18M | -96.82M | Net Income Common Stockholders |
-74.79M | -44.51M | -130.29M | -45.91M | -87.43M | -108.62M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
215.06M | 15.75M | 14.78M | 14.89M | 21.50M | 44.44M | Total Assets |
460.82M | 261.90M | 331.82M | 450.42M | 378.96M | 411.59M | Total Debt |
94.15M | 159.04M | 193.59M | 190.10M | 124.68M | 99.72M | Net Debt |
-117.56M | 143.44M | 178.96M | 175.35M | 103.47M | 55.59M | Total Liabilities |
139.67M | 210.86M | 246.13M | 242.31M | 187.43M | 149.69M | Stockholders Equity |
318.13M | 51.05M | 90.41M | 212.52M | 195.94M | 264.25M |
Cash Flow | Free Cash Flow | ||||
18.78M | 6.61M | -11.67M | -50.01M | -53.86M | -116.92M | Operating Cash Flow |
21.38M | 8.21M | -2.48M | -49.63M | -33.13M | -79.12M | Investing Cash Flow |
-346.00K | -1.56M | 1.18M | 17.33M | -14.53M | -134.82M | Financing Cash Flow |
-10.59M | -5.68M | 1.18M | 26.40M | 24.74M | 46.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | $29.43M | 17.48 | 6.18% | ― | 46.04% | ― | |
66 Neutral | C$118.17M | 5.36 | 18.60% | ― | 26.78% | ― | |
64 Neutral | $250.27M | 17.96 | 4.76% | ― | 26.93% | ― | |
63 Neutral | $40.38M | 2.98 | 20.78% | ― | -15.44% | ― | |
60 Neutral | C$147.84M | ― | -23.05% | ― | -3.73% | 32.70% | |
54 Neutral | $31.14M | ― | -16.22% | ― | 16.24% | 46.47% | |
53 Neutral | $5.14B | 3.03 | -43.89% | 2.83% | 16.75% | -0.06% |
Auxly Cannabis Group Inc. reported a strong financial performance for the first quarter of 2025, with a 29% increase in net revenues to $32.7 million and a 232% rise in adjusted EBITDA. The company maintained its position as a top player in the Canadian cannabis market, with its Back Forty brand achieving the number one spot in Canada. Auxly’s strategic focus on innovation and operational efficiency has resulted in significant growth, reinforcing its market leadership and setting a solid foundation for future expansion.
The most recent analyst rating on (IMAX) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on IMAX stock, see the IMAX Stock Forecast page.
Auxly Cannabis Group Inc. reported record sales and profitability for the fourth quarter and full year of 2024, with significant increases in net revenue and gross margins. The company reduced its total debt by 56% and achieved a notable market position with its Back Forty brand emerging as the top cannabis brand in Canada. These achievements underscore Auxly’s strong industry positioning and commitment to sustainable growth and value creation for stakeholders.